1. Home
  2. XOMA vs USAP Comparison

XOMA vs USAP Comparison

Compare XOMA & USAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • USAP
  • Stock Information
  • Founded
  • XOMA 1981
  • USAP 1994
  • Country
  • XOMA United States
  • USAP United States
  • Employees
  • XOMA N/A
  • USAP N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • USAP Steel/Iron Ore
  • Sector
  • XOMA Health Care
  • USAP Industrials
  • Exchange
  • XOMA Nasdaq
  • USAP Nasdaq
  • Market Cap
  • XOMA 320.8M
  • USAP 356.2M
  • IPO Year
  • XOMA N/A
  • USAP N/A
  • Fundamental
  • Price
  • XOMA $28.59
  • USAP $43.57
  • Analyst Decision
  • XOMA Strong Buy
  • USAP Hold
  • Analyst Count
  • XOMA 2
  • USAP 1
  • Target Price
  • XOMA $78.50
  • USAP $46.00
  • AVG Volume (30 Days)
  • XOMA 18.9K
  • USAP 240.5K
  • Earning Date
  • XOMA 11-05-2024
  • USAP 10-28-2024
  • Dividend Yield
  • XOMA N/A
  • USAP N/A
  • EPS Growth
  • XOMA N/A
  • USAP N/A
  • EPS
  • XOMA N/A
  • USAP 1.83
  • Revenue
  • XOMA $15,239,000.00
  • USAP $311,459,000.00
  • Revenue This Year
  • XOMA $456.45
  • USAP $17.53
  • Revenue Next Year
  • XOMA $29.84
  • USAP $6.99
  • P/E Ratio
  • XOMA N/A
  • USAP $23.74
  • Revenue Growth
  • XOMA 277.95
  • USAP 31.26
  • 52 Week Low
  • XOMA $14.27
  • USAP $11.13
  • 52 Week High
  • XOMA $30.50
  • USAP $45.30
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 53.55
  • USAP 64.38
  • Support Level
  • XOMA $28.66
  • USAP $43.05
  • Resistance Level
  • XOMA $30.50
  • USAP $45.30
  • Average True Range (ATR)
  • XOMA 1.07
  • USAP 1.58
  • MACD
  • XOMA 0.21
  • USAP 0.40
  • Stochastic Oscillator
  • XOMA 55.56
  • USAP 80.45

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About USAP Universal Stainless & Alloy Products Inc.

Universal Stainless & Alloy Products Inc manufactures and markets semi-finished and finished specialty steel products, including stainless steel, nickel alloys, tool steel, and certain other alloyed steels. The company along with its subsidiaries involves melting, remelting, heat treating, hot and cold rolling, forging, machining and cold drawing of semi-finished and finished specialty steels. Its products are sold to service centers, forgers, rerollers, and original equipment manufacturers.

Share on Social Networks: